The American Herbal Pharmacopoeia (AHP) has released the
first installment of a two-part Cannabis monograph, in a historic move that
classifies cannabis as a botanical medicine, alongside many other widely
accepted alternative medicines.
The cannabis monograph details long-awaited standards about
the plant’s botanical properties, including other scientific data, and provides
a foundation for healthcare professionals to incorporate marijuana therapy into
their practices.
The Executive Director for Americans for Safe Access (ASA),
an organization, which supported the development of the monograph, applauds the
AHP’s monograph, which is the first of its kind in over seventy years.
Partly because of a need for validated standards to guide
laboratory analysis, the AHP began development of the cannabis monograph in
2011. The monograph was reviewed by the world’s leading researchers and
represents one of the most comprehensive documents on cannabis in a long time.
The second installation of the monograph, the Therapeutic
Compendium, is due out in the spring. Among other topics, it will encompass
historical data, pre-clinical and clinical pharmacology and interactions with
conventional medicines.
AHP is a worldwide network of experts in medicinal plants
formed in 1995 to promote the responsible use of herbal products and medicines.
The group expects to eventually publish over 300 monographs covering the most
widely used Western, Ayurvedic and Chinese botanicals.
No comments:
Post a Comment